Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis

    Gether, L., Thyssen, Jacob Pontoppidan, Gyldenlove, M., Hartmann, Bolette, Holst, Jens Juul, Foghsgaard, S., Vilsbøll, Tina & Knop, Filip Krag, 2020, In: Diabetes, Obesity and Metabolism. 22, 11, p. 2161-2169 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight

    Schou, J. H., Pilgaard, K., Vilsbøll, Tina, Jensen, C. B., Deacon, Carolyn F., Holst, Jens Juul, Vølund, A., Madsbad, Sten & Vaag, Allan, 2005, In: Journal of Clinical Endocrinology and Metabolism. 90, 8, p. 4912-19 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

    Cypryk, K., Vilsbøll, Tina, Nadel, I., Smyczynska, J., Holst, Jens Juul & Lewinski, A., 2007, In: Gynecological Endocrinology. 23, 1, p. 58-62 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

    Sonne, David Peick, Lund, Asger Bach, Faber, J., Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Dec 2014, In: Endocrine Connections. 3, 4, p. 193-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus

    Vilsbøll, Tina, 1 Nov 2004, In: Danish Medical Bulletin (Online). 51, 4, p. 364-70 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults with Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial

    Lingvay, I., Asong, M., Desouza, C., Gourdy, P., Kar, S., Vianna, A., Vilsbøll, Tina, Vinther, S. & Mu, Y., 2023, In: JAMA. 330, 3, p. 228-237 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic

    Hansen, K. B., Svendstrup, M., Lund, A., Knop, Filip Krag, Vilsbøll, Tina & drb459, drb459, 2021, In: Diabetic Medicine. 38, 10, p. e14655

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

    Vedtofte, L., Bahne, E., Foghsgaard, S., Bagger, J. I., Andreasen, C., Strandberg, C., Gortz, P. M., Holst, Jens Juul, Gronbaek, H., Svare, J. A., Clausen, Tine Dalsgaard, Mathiesen, Elisabeth, Damm, Peter, Gluud, Lise Lotte, Knop, Filip Krag & Vilsbøll, Tina, 2020, In: Journal of Clinical Medicine. 9, 10, 14 p., 3213.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients

    Svensson, C. K., Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Koyuncu, K., Schjerning, O., Nielsen, J., Ekstrøm, Claus Thorn, Correll, C. U., Vilsbøll, Tina & Fink-Jensen, Anders, 2019, In: Acta Psychiatrica Scandinavica. 139, 1, p. 26-36 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

    Husain, M., Birkenfeld, A. L., Donsmark, M., Dungan, K., Eliaschewitz, F. G., Franco, D. R., Jeppesen, O. K., Lingvay, I., Mosenzon, O., Pedersen, S. D., Tack, C. J., Thomsen, M., Vilsbøll, Tina, Warren, M. L., Bain, S. C. & PIONEER 6 Investigators, P. 6. I., 2019, In: The New England Journal of Medicine. 381, 9, p. 841-851 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33056950